<DOC>
	<DOC>NCT00853073</DOC>
	<brief_summary>The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.</brief_summary>
	<brief_title>Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?</brief_title>
	<detailed_description>To investigate the efficacy of needle bleb revisions with mitomycin C with subconjunctival bevacizumab in promoting both filtering success and favorable bleb morphologic features.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>require glaucoma bleb needle revision with MitomycinC pregnant, nursing, or not using adequate contraception other glaucoma eye surgery involving tube shunts prior retinal detachments surgery with scleral buckle infection, inflammation, or any abnormality preventing eye pressure measurement enrolled in another investigational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>failing blebs</keyword>
	<keyword>failing express shunt</keyword>
	<keyword>avastin</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>glaucoma</keyword>
	<keyword>prior trabeculectomy</keyword>
	<keyword>Express shunt placed under a scleral flap</keyword>
	<keyword>subsequent filtration failure</keyword>
</DOC>